Home › NCT07525219
Suzetrigine Frame Trial Comparing Suzetrigine and Acetaminophen
RecruitingPhase 3
A Randomized Controlled Trial Comparing Suzetrigine and Acetaminophen for Reducing Pain During Local Anesthetic Infiltration and Head Frame Application
Who can join
Ages 21 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients scheduled for a standard of care procedure requiring a stereotactic head frame to be placed Exclusion Criteria: * Patients not scheduled for a standard of care procedure requiring a stereotactic head frame to be placed will not be approached
About the study
Local anesthetic infiltration is a primary source of acute pain during stereotactic procedures.
What is being tested
- Suzetrigine (drug)
- acetaminophen (drug)
Sponsor: Wake Forest University Health Sciences · Participants: 80 · Started: Jun 22, 2026
Contact the study team
- Wendy Jenkins, BSN RN, CCRC · Phone: 336.716.3842
Official record on ClinicalTrials.gov — NCT07525219
Locations in the U.S.
| North Carolina | Wake Forest University Health Sciences, Winston-Salem |
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.